GuidesCostLast checked August 24, 2026No dosing

GLP-1 and "GLP-2" in Canada: what they cost, and how to get them

The same molecule now spans a four-fold price range, depending on which box it comes in. Here's the honest comparison, in Canadian dollars.

Prices move, so check them again before you decide.

What a month costs, cashCanadian pharmacy and telehealth prices, Aug 2026
Generic semaglutideGLP-1$88–150
Ozempic (brand)GLP-1$250–310
Wegovy (brand)GLP-1$400–570
Mounjaro / ZepboundDual, the "GLP-2"$300–540
$0$300$600 / month
Ranges, because pharmacies vary more than people expect: the lowest generic pricing reported so far has been at Costco, whose pharmacy you can use without a membership.

The market changed more in 2026 than in the five years before it: Novo Nordisk let its Canadian semaglutide patent lapse, and Health Canada approved the first generic in April. Most of the advice I see online predates all of that, which is why I wrote this.

Which is which, in the names people use

"GLP-1" means semaglutide: Ozempic, Wegovy, and now the generics. One receptor. "GLP-2" is what people call tirzepatide, sold as Mounjaro and Zepbound. It isn't a second-generation GLP-1, it acts on GLP-1 and a second receptor called GIP, which is why it produces more weight loss and, oddly, usually less nausea.

Strictly speaking there's no drug class called GLP-2. The third one people ask about, "GLP-3", means retatrutide, and it isn't approved anywhere and can't be bought legally. I've written up the full explanation here. For this page, the names above are all you need.

The options, side by side

OptionClassWhat it isCash price
Generic semaglutideGLP-1Apo-Semaglutide and other generics, approved April 2026The cheapest route. It copies Ozempic's doses, so it's prescribed for diabetes, and off-label weight-loss prescribing is up to your prescriber.~$88–150 / month
Ozempic (brand)GLP-1Novo Nordisk semaglutide, diabetes indicationNow the expensive way to get the same molecule as the generic.~$250–310 / month
Wegovy (brand)GLP-1Semaglutide at higher, obesity-indicated dosesStill brand-only in practice. The first generic, Sevmia, was approved June 29, 2026, but pharmacies don't stock it yet.~$400–570 / month
Mounjaro / ZepboundDual, the "GLP-2"Tirzepatide, a different molecule that acts on GLP-1 and GIPThere's no generic. It's more effective on average and often better tolerated, but there's no cheap route to it yet.~$300–540 / month

Coverage, stated plainly

For weight loss, I'd assume you're paying cash. No provincial plan covers Wegovy for weight loss, and Ozempic and Mounjaro are generally covered only for type 2 diabetes. Roughly a third of Canadian employers include GLP-1s in their benefits, and most of those restrict it to diabetes as well. That's exactly why the generic launch matters so much.

Generic and brand are the same molecule

Apo-Semaglutide is semaglutide, the same as Ozempic. A Health Canada-approved generic has to demonstrate bioequivalence to the reference drug. What differs is the price, the pen device, and the approved dose range. The generics copy Ozempic's doses rather than Wegovy's higher obesity-indicated ones.

Where to ask

Your family doctor can prescribe any of these. If you don't have one, Canadian telehealth services (Felix and others) run the consult online and ship to your door. That's convenient, and usually more expensive than a pharmacy fill on a generic. Pharmacy prices vary more than people expect, the lowest generic pricing reported so far has been at Costco, and you can use their pharmacy without a membership.

About the grey market

In Canada, the price advantage of a grey-market vial over a $88 to $150 generic has largely evaporated. Research-chemical vials sold online are unapproved drugs, purity and concentration are unverified, and there's no recourse if a vial is wrong. Whatever the case for them was a year ago, the arithmetic has changed, and that's the main practical reason I'd revisit the decision.

And about "compounded semaglutide" specifically

This is the one you're most likely to be offered by something that looks legitimate (a clinic, a telehealth service, a med-spa) rather than by an obvious grey-market site. It sounds like a pharmacy product because a pharmacy is involved.

It isn't permitted in Canada, and the regulators have said so directly. Alberta's College of Pharmacy stated flatly that unauthorised compounding of semaglutide-containing products is not permitted, and the reasoning is clean. Compounding is meant to fill a gap, the gap here was a shortage of the real thing, and that shortage is over. There's an approved generic at $88 to $150 now. Whatever case existed has been filled.

Why a clinic can offer it anyway, and what a prescription does and doesn't tell you, is its own guide.

Selfsense

Once you're on something, the hard part is the record-keeping: which site you injected last, when the vial expires, and whether last week's nausea lined up with a dose change. Selfsense keeps that log and plots your weight against every dose change.

Open your record →

This page is general information. It isn't medical advice, and it isn't a recommendation of any specific treatment or provider. Prescribing decisions belong to you and a licensed healthcare professional.